Home
About
Services
Partners
Client Portfolio
News
Contact
Oil falls after U.S. softens stance on Iranian sanction waivers
July 11, 2018
Yuan, Aussie hit as U.S. threatens more tariffs on China
July 11, 2018
0
Pfizer delays drug price hikes after talking with Trump
Published by
Muller&Green
at
July 11, 2018
Categories
RSS
Tags
Pfizer Inc said on Tuesday it was deferring drug price increases for no more than six months after the company’s chief executive officer had an extensive conversation with U.S. President Donald Trump.
Powered by
WPeMatico
Muller&Green
Related posts
June 18, 2020
Chanel warns virus impact will linger on luxury sector
Read more
June 18, 2020
IMF says deeper-than-expected contraction in U.S. economy likely in second quarter
Read more
June 18, 2020
Prudential sells Jackson equity stake to Apollo-backed Athene for $500 million
Read more